Azcuna, Luzviminda C.

HRN: 24-30-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2023
AZITHROMYCIN 500MG TABLET (TAB)
12/26/2023
12/30/2023
ORAL
500mg/tab
OD
CAP-HR
Waiting Final Action 
12/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/26/2023
01/02/2024
IV
4.5g
Q8hrs
CAP-HR
Waiting Final Action 
12/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/26/2023
01/01/2024
IV
4.5gm
Q6
Cap HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: